Pharmaceutical ProductCached Profile
RIST
Active Ingredients (Generic):Unmapped
Therapeutic Area: Catheters
LIFETIME PROMOTIONAL SPEND
$11,533,368
General Payments Aggregated (2021–2024)
Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.
FDA Patient Safety Profile
Dynamic safety indicators compiled from official FDA product labels.
Active Clinical Trials
Clinical studies listing this drug as an active intervention.
Conservative Treatment of Patients With Temporomandibular Disorders
COMPLETEDPhase NANCT01021306
Biomechanical Rupture Risk Assessment in Management of Patients With Abdominal Aortic Aneurysm in COVID-19 Pandemic
UNKNOWNPhase N/ANCT05197543
Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan
COMPLETEDPhase PHASE2NCT00843947
Top Funded Physicians (Cumulative)
Doctors receiving the highest aggregate promotional support for this product.
Dr. BRIAN SNELLINGMedical Doctor$5,377,983
Dr. ERIC PETERSONMedical Doctor$5,364,345
Dr. J MOCCOMedical Doctor$114,699
Dr. ADNAN SIDDIQUIMedical Doctor$114,699
Dr. AQUILLA TURKDoctor of Osteopathy$114,699
Drug Marketing Payments Log
Federal registry records of promotional speaking, consulting, meals, and offsets.
Year:
2024
2024
2023
2022
2021
Querying Open Payments Database
Fetching live CMS.gov records for RIST...